PATENT CLAIM ANALYSIS

Application Number: 15755356
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "604000"]

Abstract:
Compounds of formula (I) having 1-sulfonamido-4-aryloxy as a basic backbone. A preliminary activity test showed that the compounds provide excellent interference of a binding of Nrf2 by Keap1, thereby activating Nrf2. The compounds have a potential anti-inflammatory activity and can be used to treat a plurality of inflammation-associated diseases, including chronic obstructive pulmonary disease (COPD), Alzheimer's disease, Parkinson's disease, atherosclerosis, chronic kidney disease (CKD), diabetes, gastroenteritis, rheumatoid arthritis, and the like.

Claim (Index 9):
A method for treating an inflammation-associated disease comprising administering to a patient in need thereof, an effective amount of the compound according to  claim 1  or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.5082
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10270259', '09972743', '11909136', '12601284', '15750427']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6989473876107849
- 35 USC 102 Novelty (BERT): 0.4843881000291804
- Combined Prediction Score: 0.6774914588526245
- Mean Citation Score: 164.202382
- Max Citation Score: 167.51404
- Similarity Product: 120.52402624338627

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test